Medicare Benefits Schedule - Item 73812

Quantitation of glycated haemoglobin (HbA1c) performed in the management of established diabetes, if performed:

(a) as a point‑of‑care test; and

(b) by or on behalf of a medical practitioner who works in a general practice that is accredited to the Royal Australian College of General Practitioners Standards for point‑of-care testing under the National General Practice Accreditation Scheme; and

(c) using a method certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrumentation used has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%)

Applicable not more than 3 times per 12 months per patient

Fee: $11.80 Benefit: 75% = $8.85 85% = $10.05

(See para PR.9.4 of explanatory notes to this Category)

• Previous - Item 73811
• Next - Item 73826

Item 73812 does not apply to a service provided to a patient who has already been provided, in the last 12 months, 4 other services to which any of the following apply:

1. item 73812;
2. item 66551;
3. item 73826.

Related Items: 73812